Wolfe Research Upgrades Corcept Therapeutics to Peer Perform

Benzinga Newsdesk www.benzinga.com Positive 94.0%

Neg 0% Neu 0% Pos 94%

Wolfe Research analyst Kalpit Patel upgrades Corcept Therapeutics (NASDAQ:CORT) from Underperform to Peer Perform.

Comments

No comments yet. Be the first!